P

PTC Therapeutics

D
PTCT
USD
0.64
(1.8038%)
Market Closed
15,538.00
Volume
-5.493
EPS
-
Div Yield
-5.724247
P/E
2,778,501,020.40
Market Cap
Today
1.8038%
1 Week
10.459%
1 Month
4.656%
6 Months
18.660%
12 Months
40.929%
Year To Date
31.202%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
S
SRPT
1.96
(1.5667%)
USD
R
RARE
1.17
(2.0316%)
USD
G
GLYC
0.0044
(2.6667%)
USD
C
CRSP
-0.11
(-0.2219%)
USD
VRTX
VRTX
3.93
(0.8292%)
USD
A
ALNY
3.06
(1.1203%)
USD
I
IONS
0.38
(0.8971%)
USD
B
BMRN
0.31
(0.4359%)
USD
REGN
REGN
11.33
(0.9948%)
USD
N
NBIX
0.63
(0.5258%)
USD

Title:
PTC Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
PTC Therapeutics Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of orally administered, small-molecule therapeutics. Its target area is RNA biology post-transcriptional control processes of the events occurring in a cell when an RNA messenger is copied from DNA during the transcription process. The discovered products address multiple therapeutic areas, including rare disorders, such as nonsense mutations in Duchenne muscular dystrophy and oncology.
Do you need help or have a question?
Contact Us